← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2016Last known activity
Sep 6, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06378879Sponsor investigatorN/ASep 6, 2024
- NCT06378879Lead sponsorN/ASep 6, 2024
- NCT06241638Sponsor investigatorN/AJul 1, 2022
- NCT06241638Lead sponsorN/AJul 1, 2022
- NCT04518930Lead sponsorN/ADec 31, 2020
- NCT04518930Reponsible party - principal investigatorN/ADec 31, 2020
- NCT03310307Reponsible party - principal investigatorPhase 2Apr 1, 2016
- NCT03310307Lead sponsorPhase 2Apr 1, 2016
Details
- Last known activity
- Sep 6, 2024